Showing results (1011-1020 of 1,030) with videos related to

Sort By:
Pageof 103
Gut|July 23, 2025
Mitochondrial dysfunction drives basal cell hyperplasia in eosinophilic oesophagitisMasaki Morimoto, Kento Kawasaki, Niamh McNamee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2026
Adjuvant Chemotherapy ± Chemoradiotherapy for Adenocarcinoma of the Pancreatic Head: Results of the Radiotherapy Random Assignment of NRG Oncology/RTOG 0848Ross A Abrams, Kathryn A Winter, Karyn A Goodman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2023
A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic AdenocarcinomaBrandon M Huffman, Hanrong Feng, Kalindi Parmar, et al.
Cancers|November 25, 2020
Effect of High-Dose vs Standard-Dose Vitamin D<sub>3</sub> Supplementation on Body Composition among Patients with Advanced or Metastatic Colorectal Cancer: A Randomized TrialJustin C Brown, Michael H Rosenthal, Chao Ma, et al.
The New England Journal of Medicine|January 18, 2023
Futibatinib for <i>FGFR2</i>-Rearranged Intrahepatic CholangiocarcinomaLipika Goyal, Funda Meric-Bernstam, Antoine Hollebecque, et al.
Cancer Discovery|July 8, 2026
Impact of vitamin D on the colon cancer immune microenvironment: results of a randomized clinical trial of preoperative vitamin D supplementation in patients with stage I-III colon cancerAndressa Dias Costa, Suryun Kim, Sung Chul Hong, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 7, 2017
NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017Al B Benson, Michael I D'Angelica, Daniel E Abbott, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 8, 2014
Hepatobiliary cancers, version 2.2014Al B Benson, Michael I D'Angelica, Thomas A Abrams, et al.
The Lancet. Infectious Diseases|March 19, 2013
Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trialEric Lawitz, Jay P Lalezari, Tarek Hassanein, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 7, 2021
Feasibility and Safety of Tethered Capsule Endomicroscopy in Patients With Barrett's Esophagus in a Multi-Center StudyJing Dong, Catriona Grant, Barry Vuong, et al.
Pageof 103